Yingqi Hua

Title: Innovations by Yingqi Hua in Tumor Cell Detection

Introduction

Yingqi Hua is an innovative inventor based in Shanghai, China. He has made significant contributions to the field of cancer detection through his research and patents. His work focuses on the detection of rare tumor cells in body fluid samples, which is crucial for advancing cancer diagnostics.

Latest Patents

Yingqi Hua holds a patent titled "Use of hexokinase-2 in detection of rare tumor cells in body fluid sample and kit." This patent relates to the use of hexokinase-2 (HK2) as a marker for detecting rare tumor cells based on abnormal tumor cell energy metabolism. The method allows for the detection of rare tumor cells with high glycolysis activity in cancer patients' body fluid samples. This innovative approach addresses the limitations of traditional detection methods that rely on epithelial markers, thereby enhancing the application of cancer liquid biopsy in clinical settings.

Career Highlights

Throughout his career, Yingqi Hua has worked with notable companies such as Suzhou Junhui Biotechnology Co., Ltd. and Hangzhou Junhui Biotechnology Co., Ltd. His experience in these organizations has contributed to his expertise in biotechnology and cancer research.

Collaborations

Yingqi Hua has collaborated with professionals in the field, including Liu Yang and Zhengdong Cai. These collaborations have further enriched his research and development efforts in tumor cell detection.

Conclusion

Yingqi Hua's innovative work in the detection of rare tumor cells represents a significant advancement in cancer diagnostics. His contributions through patents and collaborations highlight the importance of research in improving clinical applications for cancer detection.